Arcus Biosciences (RCUS)
(Delayed Data from NYSE)
$15.42 USD
+0.13 (0.85%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $15.41 -0.01 (-0.06%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $-0.86 | 0.00% |
Earnings Summary
For their last quarter, Arcus Biosciences (RCUS) reported earnings of -$1.02 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for RCUS's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of -$0.86 per share, reflecting a year-over-year increase of 8.51%.
Earnings History
Price & Consensus
Zacks News for RCUS
Janux Therapeutics, Inc. (JANX) Reports Q2 Loss, Tops Revenue Estimates
RCUS: What are Zacks experts saying now?
Zacks Private Portfolio Services